Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Summary

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Neuroblastoma, Breast Cancer and other specialties. Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is involved with conducting 295 clinical trials across 461 conditions. There are 48 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mothaffar Rimawi, MD, and Ahmed Elkhanany.

Top PIs

Clinical Trials running at Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Cancer

Lung Cancer

Breast Cancer

Brain Tumor

Breast cancer

Bladder Cancer

Wilms Tumor

Testicular cancer

Neuroblastoma

Pancreatic Cancer

Letermovir

for Preventing Infection After Stem Cell Transplant in Blood Cancer

This phase III single arm trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant compared to estimated rate of infection without prophylaxis. The treatments used to prepare for HCT reduce the body's natural infection-fighting ability and increase the likelihood of an infection with a virus called cytomegalovirus. "Prophylaxis" means to take a drug to prevent a disease or side effect. Letermovir is an antiviral drug that stops cytomegalovirus from multiplying and may prevent cytomegalovirus infection and make the disease less severe.

Recruiting

2 awards

Phase 3

5 criteria

Cooling/Compression Therapy

for Chemotherapy-Induced Peripheral Neuropathy

This trial tests three methods to prevent nerve damage in patients receiving taxane chemotherapy. The methods involve using special wraps that either cool the limbs, apply steady pressure, or apply gentle pressure that comes and goes. These approaches aim to protect nerves from the harmful effects of chemotherapy drugs. Cooling the limbs has been well-tolerated and is a reasonable option to prevent nerve damage in patients receiving taxane-based treatments.

Recruiting

2 awards

Phase 3

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria